N-Hexadecanoyl-D-erythro-sphingosine惠诚

H1915

N-十六酰基-D-赤式-鞘氨醇 N-Hexadecanoyl-D-erythro-sphingosine

24696-26-2

synthetic

C₃₄H₆₇NO₃

538

10mg

solid

98+% TLC, GC

N-C16:0-D-erythro-Ceramide; N-Palmitoyl-D-erythro-sphingosine

chloroform, warm ethanol, warm methanol

-20°C

1. M. Morrow et al. “Ceramide-1-phosphate, in contrast to ceramide, is not segregated into lateral lipid domains in phosphatidylcholine bilayers” Journal of Biophysics, Vol. 96(6) pp. 2216-2226, 2009
2. F. Dupuy, M. Fanani, and B. Maggio “Ceramide N-Acyl Chain Length: A Determinant of Bidimensional Transitions, Condensed Domain Morphology, and Interfacial Thickness” Langmuir, 2011, DOI: 10.1021/la105011x
3. J. M. Hauser, B. M. Buehrer, and R. M. Bell “Role of ceramide in mitogenesis induced by exogenous sphingoid bases.” Journal of Biological Chemistry Vol. 269 pp. 6803, 1994
4. N. S. Radin, “Killing tumours by ceramide-induced apoptosis: a critique of available drugs” Biochemical Journal, Vol. 371 pp. 243-256, 2003
5. N. S. Radin, “Designing anticancer drugs via the achilles heel: ceramide, allylic ketones, and mitochondria” Bioorganic and Medicinal Chemistry, Vol. 11(10) pp. 2123-2142, 2003